Citation Impact
Citing Papers
Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study
1994
Sirtuins as regulators of metabolism and healthspan
2012 Standout
Evolutionary History of a Specialized P450 Propane Monooxygenase
2008 StandoutNobel
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
2009 Standout
SIRT1 Deacetylates and Positively Regulates the Nuclear Receptor LXR
2007
Frequency-Band Coupling in Surface EEG Reflects Spiking Activity in Monkey Visual Cortex
2009
Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy
1996
Rheumatoid arthritis
2016 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy
1985
Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease
1994
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Plasma exchange for Guillain-Barré syndrome
2002
Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies
1995
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Fate of Endogenously Synthesized Cholesterol in Niemann-Pick Type C1 Cells
2000
Oxysterols are allosteric activators of the oncoprotein Smoothened
2012
Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRα
1998
Cholesterol Depletion Induces Solid-like Regions in the Plasma Membrane
2005 StandoutNobel
Alzheimer's disease
2011 Standout
Guillain-Barré syndrome
2016 Standout
Plasma exchange for Guillain-Barré syndrome
2012
Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice
2001
Guillain–Barré Syndrome
2012 Standout
Glutathione depletion switches nitric oxide neurotrophic effects to cell death in midbrain cultures: implications for Parkinson's disease
2001
Determination of pain and response to methylprednisolone in Guillain-Barré syndrome
2007
Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects
1988
Visual and motor evoked potentials in the course of multiple sclerosis
2001
Rehabilitation of Guillain-Barré syndrome
1997
Oxysterols and atherosclerosis
1999
The Guillain–Barré Syndrome
1992
Treatment of Guillain-Barr� syndrome: A cost-effectiveness analysis
1999
Parkinson's disease
2009 Standout
T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barré syndrome
1997
Limited Relapse in Guillain-Barre Syndrome After Plasma Exchange
1988
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Multiple sclerosis
2008 Standout
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
2000 Standout
Electrophysiologic studies in the Guillain–Barré syndrome: Effects of plasma exchange and antibody rebound
1992
Motor conduction studies in guillain‐barré syndrome: Description and prognostic value
1988
Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barre syndrome
2003
Statins for the prevention of dementia
2009
Immunotherapy for Guillain-Barre syndrome: a systematic review
2007
Outcome and its predictors in Guillain–Barré syndrome
2012
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
The Effect of Simvastatin Treatment on the Amyloid Precursor Protein and Brain Cholesterol Metabolism in Patients with Alzheimer’s Disease
2005
Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen.
1989
Lipoprotein abnormalities in patients with extra-coronary arteriosclerosis
1990
Reduction in Levels of 24S-Hydroxycholesterol by Statin Treatment in Patients With Alzheimer Disease
2003
The LXRs: a new class of oxysterol receptors
1998
Treatment interventions for Parkinson's disease: an evidence based assessment
2002
The Glymphatic System: A Beginner’s Guide
2015 Standout
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Alzheimer's disease
2006 Standout
Immunopathogenesis and treatment of the guillain‐barré syndrome—part I
1995
Effects of membrane cholesterol on the sensitivity of the GABAA receptor to GABA in acutely dissociated rat hippocampal neurones
2001
Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial
2009
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Inflammation as a causative factor in the aetiology of Parkinson's disease
2007
Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26‐week randomized, placebo‐controlled, double‐blind trial
2002
Review: Contribution of transgenic models to understanding human prion disease
2010
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Paresis Acquired in the Intensive Care Unit<SUBTITLE>A Prospective Multicenter Study</SUBTITLE>
2002 Standout
Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease
2005
Acquired inflammatory demyelinating polyneuropathies: Clinical and electrodiagnostic features
1989
Alzheimer's Disease
2010 Standout
Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults
1999 Standout
Cholesterol Depletion Suppresses the Translational Diffusion of Class II Major Histocompatibility Complex Proteins in the Plasma Membrane
2004 StandoutNobel
Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway
1997
The Role of Glial Reaction and Inflammation in Parkinson's Disease
2003
The Amyloid State of Proteins in Human Diseases
2012 Standout
Modulation of Secreted β-Amyloid Precursor Protein and Amyloid β-Peptide in Brain by Cholesterol
1998
Transcranial Magnetic Stimulation: A Primer
2007 Standout
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
The Economic Burden ofCampylobacter‐AssociatedGuillain‐Barré Syndrome
1997
Experience of double filtration plasmapheresis in the treatment of Guillain-Barr� syndrome
1999
Residual signs in severe Guillain-Barré syndrome: analysis of 57 patients
1991
Guillain-Barré syndrome
2005 Standout
High density lipoprotein cholesterol and arteriography in intermittent claudication
1989
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
1993 Standout
Peroxynitrite and Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease
2003
Metallothionein Attenuates 3-Morpholinosydnonimine (SIN-1)-Induced Oxidative Stress in Dopaminergic Neurons
2003
Nitric oxide neurotoxicity in neurodegenerative diseases
2004
Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier
2019 StandoutNobel
Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ
1999 Nobel
Residual health status after Guillain-Barre syndrome.
1997
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol
2003 StandoutNobel
Trace polypeptides in cellular extracts and human body fluids detected by two-dimensional electrophoresis and a highly sensitive silver stain.
1979
Editorial Expression of Concern for multiple articles
2008 StandoutNobel
Intravenous immunoglobulin for Guillain-Barré syndrome
2014
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
Plasma Lipid Profile and Incident Ischemic Stroke
2003
FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces,In Vitro,Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells
1999
Sterols and Isoprenoids: Signaling Molecules Derived from the Cholesterol Biosynthetic Pathway
1999
Identification of a 24-kDa cytokine that is required for development of cytolytic T lymphocytes.
1988 StandoutNobel
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.
1993 Standout
Pain in Guillain-Barré syndrome
2010
Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease
2007
Polyneuropathy in critically ill patients.
1984
Efficient isolation of genes by using antibody probes.
1983 Standout
Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger
2008 StandoutNobel
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths
2007 Standout
FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.
1999
Neuronal DNA damage response‐associated dysregulation of signalling pathways and cholesterol metabolism at the earliest stages of A lzheimer‐type pathology
2015
A Randomized Trial Comparing Intravenous Immune Globulin and Plasma Exchange in Guillain–Barré Syndrome
1992 Standout
The Relationship of Fibrinogen and Factors VII and VIII to Incident Cardiovascular Disease and Death in the Elderly
1999
Nitric oxide prevents axonal degeneration by inducing HIF-1–dependent expression of erythropoietin
2011 StandoutNobel
Ultrasensitive Stain for Proteins in Polyacrylamide Gels Shows Regional Variation in Cerebrospinal Fluid Proteins
1981 StandoutScience
Development of a Point of Care Lateral Flow Device for Measuring Human Plasma Fibrinogen
2010 StandoutNobel
SERUM HIGH-DENSITY LIPOPROTEINS IN PERIPHERAL VASCULAR DISEASE
1978
Identification of a Nuclear Receptor for Bile Acids
1999 StandoutScience
Two-dimensional gel electrophoresis of cerebrospinal fluid proteins.
1980
Oxidative stress in neurodegeneration: cause or consequence?
2004 Standout
Plasmapheresis and guillain‐barré syndrome: Analysis of prognostic factors and the effect of plasmapheresis
1988
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.
1980
Works of Å Sidén being referenced
A clinical study of the Guillain-Barré syndrome
2009
Nosocomial transmission of sporadic Creutzfeldt-Jakob disease: results from a risk-based assessment of surgical interventions
2010
Increased cerebrospinal fluid concentration of nitrite in Parkinsonʼs disease
1995
Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation.
1996
BENEFICIAL EFFECTS OF PLASMA EXCHANGE IN ACUTE INFLAMMATORY POLYRADICULONEUROPATHY
1984
NORMAL SERUM-CHOLESTEROL BUT LOW H.D.L.-CHOLESTEROL CONCENTRATION IN YOUNG PATIENTS WITH ISCHÆMIC CEREBROVASCULAR DISEASE
1978
Isoelectric focusing and crossed immunoelectrofocusing of CSF immunoglobulins in MS
1979
A comparison of motor evoked potentials and somatosensory evoked potentials in patients with multiple sclerosis and potentially related conditions.
1995
Electrofocusing and Electrophoresis of Cerebrospinal Fluid Proteins in CNS Disorders of Known or Probable Infectious Etiology
1977
Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuations
1998
Aberrant CSF Protein Fractions Found by Electrofocusing in Multiple Sclerosis
1977
Dyslipoproteinemia in patients with ischemic cerebro-vascular disease A study of stroke before the age of 55
1978
Neuropathies Associated with Disorders of Plasmocytes
1980
An analysis of VEP components in optic neuritis.
1995
Factor VIII related antigen, antithrombin III, spontaneous platelet aggregation and plasminogen activator in ischemic cerebrovascular disease
1979